EMDF Med Future Appoints New CEO
Friday , January 07, 2005 09:22 ET
COLUMBUS, Ohio, Jan 7, 2005 (BUSINESS WIRE) --The Executive Board of E Med Future, Inc. (OTCBB:EMDF) has appointed D. Dane Donohue President & Chief Executive Officer. The appointment immediately followed the resignation of Robert J. Ochsendorf, the company's former President and CEO, on January 3, 2005. Donohue is one of the co-founders of E Med and served as Executive Vice President since the company's inception. In a letter to the directors, Ochsendorf cited health reasons and personal matters that needed his immediate attention.
"With increasing global awareness of our inaugural product NeedleZap(R), the top position of E Med requires much more time and effort than I am able to contribute. I am confident that NeedleZap(R) and other products currently under development will enable E Med to continue its growth and promising future with Dane Donohue as CEO," Ochsendorf said.
Donohue and others praised Ochsendorf for the selfless and tireless efforts that he dedicated to E Med Future during its developmental years. "We are all eternally grateful for the hard work that Bob poured into the company to help create worldwide awareness of NeedleZap(R)," said Donohue. "I want to express my heartfelt thanks, and best wishes for a healthier lifestyle to my life long friend."
Donohue further stated, "We are at the dawn of the next level for E Med Future, and I look forward to continuing Bob's efforts in leading the company toward that prosperity." Ochsendorf will continue to serve as a director.
For more information about E Med Future or NeedleZap(R), call 877-855-1319 or visit www.needlezap.com.
Statements that describe E Med's future plans, objectives or goals are forward-looking statements. These forward-looking statements can generally be identified as such because the context of the statement will include words such as E Med "expects," "anticipates" or words of similar import. Such forward-looking statements are subject to certain risks and uncertainties, including the financial performance of E Med, as appropriate, and market valuations of their stock, which could cause actual results to differ materially from those currently anticipated. Please refer to E Med's 10-K, 10-Qs and other filings with the SEC for a description of other factors that could cause actual results to differ from those anticipated.
SOURCE: E Med Future, Inc.
E Med Future, Inc.
Don Sullivan, 877-855-1319
Copyright (C) 2005 Business Wire. All rights reserved.
Market Data 
Markets 
AI
